AMN Healthcare Invests in Leading Telepharmacy Company PipelineRx
Partnership Enhances AMN Workforce Solutions Offering
AMN Healthcare, the innovator in healthcare workforce solutions and
largest provider of staffing services in the nation, announced today it
has made a strategic investment in PipelineRx, a leading clinical
"Our investment in PipelineRx is a testament to our commitment to
investing in innovative solutions to help clients manage their workforce
and patient care commitments in the wake of unprecedented changes in
the healthcare environment. PipelineRx's telepharmacy offerings address
significant healthcare access challenges in a cost-effective manner and
increase the quality and safety of care delivered," said Susan Salka,
AMN's President and CEO. "We look forward to working closely with
PipelineRx to further its mission and identify ways that AMN can
leverage our pharmacy staffing division and client relationships to
create synergies for both companies."
PipelineRx offers telepharmacy services and technology solutions
designed to help hospitals provide cost-efficient pharmacist coverage 24
hours a day with improved patient care. PipelineRx's Clinical Process
Outsourcing (CPO) solution uses a private network of quality clinical
telepharmacists to replicate and extend the same cognitive clinical
roles and responsibilities of a hospital's onsite clinical pharmacists.
PipelineRx also offers its technology as a Software as a Service
(SaaS) solutions platform to clients that prefer to use the PipelineRx
workflow technology with the hospital's internal pharmacists. This
proprietary technology platform optimizes pharmacy operations and labor,
streamlines disparate processes, improves financial performance, and
helps facilitate government mandates related to verification of
electronic physician orders.
"We are pleased to be partnering with AMN Healthcare as we continue
to expand the market for our telepharmacy solutions and grow our
business in 2014 and beyond. AMN's investment validates our unique
approach to improving efficiency in our healthcare system and to drive
measurable and enhanced quality of care for patients through the use of
cutting-edge technology," said Brian J. Roberts,
President of PipelineRx. "With AMN's workforce solutions expertise and
staffing services leadership, we look forward to what we can accomplish
together to help hospitals achieve financial and patient care goals."
AMN has committed to a $5.0 million investment in staged payments. In conjunction with the investment, AMN also announced that Denise Jackson,
General Counsel and Senior Vice President, has joined the PipelineRx
Board of Directors. Ms. Jackson will serve as an advisor to the company,
drawing upon her experience building AMN's corporate capabilities and
nearly 15 years' experience in the healthcare staffing and workforce
PipelineRx is the leading independent technology-enabled
telepharmacy solutions provider serving acute and specialty hospitals.
The Company's pharmacy workforce solutions enable hospitals to
dramatically increase operating efficiencies while ensuring medication
efficacy, increasing patient safety, and improving clinical outcomes.
PipelineRx differentiates its unique services via its integrated,
private, cloud-based technology platform and its optimized, distributed
telepharmacist network. PipelineRx is privately held and is
headquartered in San Francisco, CA.
This press release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. The
Company based these forward-looking statements on its current
expectations, estimates and projections about future events and the
industry in which it operates using information currently available to
it. Actual results could differ materially from those discussed in, or
implied by, these forward-looking statements. Forward-looking statements
are identified by words such as "believe," "anticipate," "expect,"
"intend," "plan," "will," "may," "estimates," variations of such words
and other similar expressions. In addition, any statements that refer to
expectations, projections or other characterizations of future events
or circumstances are forward-looking statements. Factors that could
cause actual results to differ from those implied by the forward-looking
statements contained in this press release are set forth in the
Company's Annual Report on Form 10-K for the year ended December 31, 2013
and its other periodic reports as well as the Company's current and
other reports filed from time to time with the Securities and Exchange
Commission. Be advised that developments subsequent to this press
release are likely to cause these statements to become outdated with the
passage of time.